Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Solaris Energy Infrastructure Inc. Class A Common Stock (SEI) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Solaris Energy Infrastructure Inc. Class A Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Solaris Energy Infrastructure Inc. Class A Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Solaris Energy Infrastructure Inc. Class A Common Stock trades at $68.5 (market cap $5.12B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Solaris Energy Infrastructure Inc. Class A Common Stock is far larger — about 2.8× Vir Biotechnology Inc. Common Stock's market cap, and Solaris Energy Infrastructure Inc. Class A Common Stock pays a 0.62% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Solaris Energy Infrastructure Inc. Class A Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

SEIVIR
Market Cap
$5.12B$1.80B
Volume
2,532,4961,782,836
Sector
EnergyHealth
52-Week High
$82.88$11.78
52-Week Low
$40.64$5.12
Typical Hold Time
0 Days0 Days
Enterprise Value
$6.81B$1.36B
Dividend Yield
0.62%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Solaris Energy Infrastructure Inc. Class A Common Stock

SEI (Solaris Energy Infrastructure) trades at $77.83, down 1.83% today, but maintains strong analyst support with 9 unanimous buy ratings and a $100.56 consensus price target. The stock shows positive momentum with three consecutive quarterly earnings beats and projected revenue growth from $622M in 2025 to $762M in 2026. Recent technical analysis indicates neutral signals with support at $76 and resistance at $79.

The outlook remains positive given strong earnings performance and expansion initiatives, though elevated valuation ratios (P/E of 98.52) and significant debt issuance ($1.25B notes) present risks. The upcoming Q3 2026 earnings report on October 21 will be crucial for validating growth trajectory amid energy sector volatility.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SEI
100% Buy0% Sell
Avg holding period · 0 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Solaris Energy Infrastructure Inc. Class A Common Stock

Solaris Energy Infrastructure, Inc. provides mobile power generation, control, and distribution equipment and logistics equipment for managing raw materials at well sites, operating through its Solaris Power Solutions and Solaris Logistics Solutions segments for data center, energy, commercial, and industrial customers.

Read more on SEI →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →